COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)

Background: A few prospective trials and case series have suggested that hyperbaric oxygen therapy (HBOT) may be efficacious for the treatment of severe COVID-19, but safety is a concern for critically ill patients. We present an interim analysis of the safety of HBOT via a randomized controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjellberg, Anders, Douglas, Johan, Hassler, Adrian, Al-Ezerjawi, Sarah, Boström, Emil, Abdel-Halim, Lina, Liwenborg, Lovisa, Hetting, Eric, Jonasdottir Njåstad, Anna Dora, Kowalski, Jan, Catrina, Sergiu-Bogdan, Rodriguez-Wallberg, Kenny A., Lindholm, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381696/
https://www.ncbi.nlm.nih.gov/pubmed/37510965
http://dx.doi.org/10.3390/jcm12144850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381696/
https://www.ncbi.nlm.nih.gov/pubmed/37510965
http://dx.doi.org/10.3390/jcm12144850

Ejemplares similares